Participants 108 140 4
population-based screening study
Participants 597 607 6
10,865 men
Participants 650 693 7
1202 men with PSA levels of 4 ng/mL or more
Participants 1200 1217 5
1202 men studied,
Participants 1231 1246 5
prostate cancer
